Alida Biosciences is developing the next generation of RNA analysis tools to enable new medical treatments and diagnostic assays.
Total raised: $7.5M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 12.06.2024 | Series A | $7.5M | - |
Mentions in press and media 4
| Date | Title | Description |
| 12.06.2024 | Alida Biosciences Pioneers Epitranscriptomic Research with $7.5M Series A Funding | Alida Biosciences, a cutting-edge biotech company based in San Diego, has recently made waves in the scientific community by securing a substantial $7.5 million in Series A funding. Spearheaded by the visionary leadership of Dr. Gudrun Sten... |
| 12.06.2024 | AlidaBio Secures $7.5M to Optimize Epitranscriptomic Research | What You Should Know: – Alida Biosciences (AlidaBio), an innovator in epigenomic research tools, proudly announces the successful completion of a $7.5 million Series A funding round. This funding, led by Genoa Ventures with participation fr... |
| 12.06.2024 | Alida Biosciences Raises $7.5M in Series A Funding | Alida Biosciences, a San Diego, CA-based innovator in epigenomic research tools, raised $7.5m in Series A funding. The round was led by Genoa Ventures with participation from FusionX Ventures and Vertical Venture Partners. The company inten... |
| - | Alida Biosciences | “Home - AlidaBio” |